Johan Linderoth
Impact in
-
- Lymphoma Diagnosis and Treatment
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 22
- Oncology 10
- Viral-associated cancers and disorders 5
- Co-authors
- Mats Jerkeman (13 shared papers)Eva Cavallin‐Ståhl (8 shared papers)Gunilla Enblad (11 shared papers)Mattias Berglund (6 shared papers)Martin Erlanson (5 shared papers)Michael Dictor (3 shared papers)Emina Torlakovic (2 shared papers)Stein Kvaløy (2 shared papers)
In The Last Decade
Johan Linderoth
23 papers receiving 567 citations
Peers
Comparison fields: 5 of 51
- Pathology and Forensic Medicine 384
- Genetics 131
- Oncology 209
- Neurology 79
- Immunology 81
Countries citing papers authored by Johan Linderoth
This map shows the geographic impact of Johan Linderoth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Linderoth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Linderoth more than expected).
Fields of papers citing papers by Johan Linderoth
This network shows the impact of papers produced by Johan Linderoth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Linderoth. The network helps show where Johan Linderoth may publish in the future.
Co-authors
The 25 scholars most cited alongside Johan Linderoth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 161 | |
| 2 | Immunohistochemical expression of CD23 and CD40 may identify prognostically favorable subgroups of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Study. | 2003 | 80 |
| 3 | 2007 | 48 | |
| 4 | 2008 | 34 | |
| 5 | 2008 | 32 | |
| 6 | 2015 | 29 | |
| 7 | 2009 | 26 | |
| 8 | 2007 | 24 | |
| 9 | 2019 | 18 | |
| 10 | 2016 | 18 | |
| 11 | 1999 | 14 | |
| 12 | 2008 | 13 | |
| 13 | 2007 | 13 | |
| 14 | 2011 | 13 | |
| 15 | 2017 | 12 | |
| 16 | 2016 | 11 | |
| 17 | 2010 | 11 | |
| 18 | 2012 | 10 | |
| 19 | 2021 | 5 | |
| 20 | 2022 | 5 |
About Johan Linderoth
Johan Linderoth is a scholar working on Pathology and Forensic Medicine, Oncology, Neurology, Immunology and Pulmonary and Respiratory Medicine, having authored 25 papers that have together received 582 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (22 papers), CNS Lymphoma Diagnosis and Treatment (6 papers), Viral-associated cancers and disorders (5 papers), Lung Cancer Treatments and Mutations (4 papers), Cutaneous lymphoproliferative disorders research (3 papers), Multiple and Secondary Primary Cancers (2 papers), Ubiquitin and proteasome pathways (2 papers) and Galectins and Cancer Biology (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (384 citations), Genetics (131 citations), Oncology (209 citations), Neurology (79 citations) and Immunology (81 citations). Johan Linderoth has collaborated with scholars based in Sweden, Norway and Denmark. Frequent co-authors include Mats Jerkeman, Eva Cavallin‐Ståhl, Gunilla Enblad, Mattias Berglund, Martin Erlanson, Michael Dictor, Emina Torlakovic, Stein Kvaløy, Mats Ehinger and Göran Roos. Their work appears in journals such as British Journal of Haematology, HemaSphere, American Journal of Clinical Pathology, Experimental Cell Research and The Journal of Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.